|
gptkbp:instance_of
|
gptkb:Antihero
|
|
gptkbp:approves
|
gptkb:1956
|
|
gptkbp:atccode
|
N05 BA01
|
|
gptkbp:brand
|
Atarax
Vistaril
|
|
gptkbp:casnumber
|
50-53-3
|
|
gptkbp:category
|
Category C
|
|
gptkbp:chemical_formula
|
C21 H27 Cl N2 O2
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:composed_by
|
synthetic
|
|
gptkbp:contraindication
|
gptkb:asthma
gptkb:Ophthalmology
severe respiratory depression
allergy to hydroxyzine
|
|
gptkbp:discovery_year
|
1950s
|
|
gptkbp:dosage_form
|
100 mg
50 mg
25 mg
10 mg/ml
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
gptkb:tablet
gptkb:Sugar
injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
hydroxyzine
|
|
gptkbp:interacts_with
|
gptkb:beer
CNS depressants
MAO inhibitors
opioids
|
|
gptkbp:legal_status
|
Prescription only
|
|
gptkbp:mechanism_of_action
|
H1 receptor antagonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:related_to
|
gptkb:chlorpheniramine
gptkb:diphenhydramine
gptkb:promethazine
cetirizine
fexofenadine
|
|
gptkbp:route_of_administration
|
oral
intramuscular
|
|
gptkbp:side_effect
|
dizziness
drowsiness
constipation
dry mouth
blurred vision
|
|
gptkbp:used_for
|
anxiety
nausea
allergic reactions
insomnia
|
|
gptkbp:bfsParent
|
gptkb:Benadryl
|
|
gptkbp:bfsLayer
|
6
|